Market Intelligence and Reports

Worldwide Market for Clinical Laboratory Services, 10th Edition provides a definitive analysis of the global clinical lab services industry, offering critical insights into market size, growth drivers, testing types in demand, and competitive positioning from 2024 to 2029. This report is a key resource for stakeholders seeking to understand diagnostic service dynamics in the wake…

Kalorama Information’s Women’s Health Diagnostic Markets: Global Outlook and Forecast to 2030 offers a comprehensive, data-driven analysis of the global landscape for diagnostic tests that specifically address women’s health across clinical, point-of-care (POC), and over-the-counter (OTC) settings. As global demographics shift—with women living longer than men—healthcare systems are under increasing pressure to recognize and address…

The CGT market is evolving rapidly, with billions in investments and thousands of strategic deals shaping its trajectory. Companies that understand the landscape and anticipate future deal trends will have the competitive edge needed to thrive. Whether you are a biotech executive, investor, R&D leader, or regulatory strategist, this report provides data-driven insights to inform…

Kalorama Information’s Cell and Gene Therapy Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2024 offers a comprehensive look at the dynamic and rapidly evolving cell and gene therapy market. This report highlights the significant deal-making activities that have taken place from Q1 2021 to Q1 2024, providing valuable insights for companies and…

In the Life Science industry, in-person scientific conferences have always been a valuable channel for the communication and discussion of new and innovative research or breakthroughs. Not only do conference attendees use these opportunities to network, explore, and investigate what is next on the horizon in their fields, they also directly interact with life science…

Explore the dynamic world of cell and gene therapy deal-making with Kalorama Information’s comprehensive report, Cell and Gene Therapy Funding and Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2023. This report tracks the deal-making activities in cell and gene therapy since 2021, providing insightful graphs of quarterly trends from 2021-2023 and detailing…

Description:

Out-of-pocket (OOP) healthcare expenses in the United States are on the rise due to various demographic, business, and government trends. Out-of-Pocket Spending in Healthcare (Pharmaceuticals, Surgeries, Tests, Electives, Premiums, Copays, Doctor Visits, Other), 6th Edition delves into these trends, focusing on the financial aspects of OOP spending growth. It provides forecasts of total expenditures…

The Market for Rx-to-OTC Switches, 8th Edition provides an in-depth analysis of the dynamic U.S. Rx-to-OTC switch market, which has grown into a double-digit multi-billion-dollar industry driven by patent expirations, increased competitiveness, FDA collaboration, brand reinvention, consumer demand, and cost containment strategies.

 

Report Highlights:

• Market Dynamics:
  • Examination of the transition of over…

The cell and gene therapy (CGT) sector has experienced remarkable growth, with funding reaching $70 billion in 2021. As barriers to entry lower and the number of approved therapies with proven track records increases, over a thousand companies have entered or expanded within this dynamic field. Keeping up with this rapidly evolving industry is essential,…

Rising out-of-pocket (OOP) healthcare expenses in the United States are driven by a variety of demographic, business, and government trends. Kalorama Information’s report, Out-of-Pocket (OOP) Healthcare Expenditures in the United States, 5th Edition, delves deeply into these trends, focusing on the financial aspects of OOP spending growth and providing forecasts for total expenditures and specialized…

The chemical industry, sandwiched downstream of oil & gas and upstream of pharmaceuticals, foods, and other manufacturing industries, is the backbone of most industrial processes, providing the key raw materials needed for the vast majority of end-use consumer products. Encompassing commodity chemicals, specialty chemicals, and fine chemicals, laboratories within this industry comprise about 5% of…